Unicorn Nest Logo

Cathay Capital

www.cathaycapital.com
Total investments

59

Average round size

59M

Portfolio companies

54

Rounds per year

3.28

Lead investments

14

Follow on index

0.08

Exits

2

Areas of investment
BiotechnologyE-CommerceSoftwareInformation TechnologyArtificial IntelligenceHealth CareRoboticsManufacturingMedicalElectronics

Investments analytics

Analytics

Total investments
59
Lead investments
14
Exits
2
Rounds per year
3.28
Follow on index
0.08
Investments by industry
  • Health Care (12)
  • Artificial Intelligence (7)
  • Biotechnology (7)
  • Manufacturing (7)
  • E-Commerce (6)
    • Show 89 more
Investments by region
  • China (40)
  • Italy (1)
  • France (9)
  • United States (4)
  • New Zealand (1)
    • Show 3 more
Peak activity year
2021
Number of Unicorns
2
Number of Decacorns
3
Number of Minotaurs
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
404M
Group Appearance index
0.80
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Avistone Pharmaceuticals 28 Dec 2023 Biotechnology Early Stage Venture 154M Beijing, Beijing, China
Svolt Energy Technology Co. 22 Mar 2021 Energy Storage, Manufacturing, Energy, Electric Vehicle, Battery Early Stage Venture Hebei, Baoding City, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.